0001493152-17-007275.txt : 20170628
0001493152-17-007275.hdr.sgml : 20170628
20170628170914
ACCESSION NUMBER: 0001493152-17-007275
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170628
DATE AS OF CHANGE: 20170628
EFFECTIVENESS DATE: 20170628
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001710340
IRS NUMBER: 371858472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-289651
FILM NUMBER: 17936059
BUSINESS ADDRESS:
STREET 1: 12264 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-704-4040
MAIL ADDRESS:
STREET 1: 12264 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
D
1
primary_doc.xml
X0707
D
LIVE
0001710340
Eton Pharmaceuticals, Inc.
12264 EL CAMINO REAL
SUITE 350
SAN DIEGO
CA
CALIFORNIA
92130
858-704-4040
DELAWARE
None
None
Corporation
true
2017
Sean
Brynjelsen
12264 EI Camino Reai
Suite 350
San Diego
CA
CALIFORNIA
92130
Executive Officer
Director
Mark
Baum
12264 EI Camino Real
Suite 350
San Diego
CA
CALIFORNIA
92130
Director
Andrew
Boll
12264 EI Camino Real
Suite 350
San Diego
CA
CALIFORNIA
92130
Director
Charles
Casamento
12264 EI Camino Real
Suite 350
San Diego
CA
CALIFORNIA
92130
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2017-06-19
false
true
false
0
National Securities Corporation
7569
None
None
410 PARK AVENUE
NEW YORK
NY
NEW YORK
10022
AR
ARKANSAS
CA
CALIFORNIA
CO
COLORADO
FL
FLORIDA
IL
ILLINOIS
LA
LOUISIANA
MD
MARYLAND
MI
MICHIGAN
MN
MINNESOTA
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
PA
PENNSYLVANIA
TX
TEXAS
VA
VIRGINIA
WA
WASHINGTON
WI
WISCONSIN
false
20055210
20055210
0
false
230
1958221
0
Recipient also received a warrant to purchase up to 652,740 shares of the Issuer's common stock.
0
false
Eton Pharmaceuticals, Inc.
/s/ Sean Brynjelsen
Sean Brynjelsen
Chief Executive Officer
2017-06-28